Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ALKEM stock hub

NSE/ALKEM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ALKEMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

667.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ALKEM

In the news

Latest news · NSE/ALKEM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E28.6

P25 24.9P50 32.4P75 45.7

Trailing P/E28.2

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC19.2

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ALKEM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

INR

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	18,785
Employees Change	1,353%
Employees Change Percent	7.76
Enterprise value	INR 644.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE540L01014
Last refreshed	2026-05-10
Market cap	INR 667.8B
Price	INR 5,560
Price currency	INR
Rev Per Employee	7,587,277.08x
Sector	Healthcare
Sic	2834
Symbol	nse/ALKEM
Website	https://www.alkemlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.55%
EV Earnings	27.18x
EV/EBIT	25.94x
EV/EBITDA	22.48x
EV/Sales	4.52x
Forward P/E	28.56x
P/B ratio	4.84x
P/E ratio	28.17x
P/S ratio	4.69x
PE Ratio10 Y	29.07x
PE Ratio3 Y	31.92x
PE Ratio5 Y	30.23x
PEG ratio	2.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.45%
EBITDA Margin	19.89%
Gross margin	62.92%
Gross Profit	INR 89.7B
Gross Profit Growth	11.57%
Gross Profit Growth Q	13.56%
Gross Profit Growth3 Y	11.91%
Gross Profit Growth5 Y	11.54%
Net Income	INR 23.7B
Net Income Growth	10.13%
Net Income Growth Q	1.63%
Net Income Growth Quarters	11%
Net Income Growth Years	2%
Net Income Growth3 Y	32.44%
Net Income Growth5 Y	9.1%
Pretax Margin	19.94%
Profit Margin	16.64%
Profit Per Employee	INR 1.3M
Profitable Years	16
Roa5y	8.13
Roe5y	18.39
ROIC	19.24
Roic5y	17.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.23%
Cagr1y	11.55%
Cagr3y	18.13%
Cagr5y	15.01%
Div CAGR3	5.04%
Div CAGR5	12.74%
EPS Growth	10.12
EPS Growth Q	1.62
EPS Growth Quarters	11
EPS Growth Years	2
EPS Growth3 Y	32.44
EPS Growth5 Y	9.1
Revenue Growth	11.73x
Revenue Growth Q	10.74x
Revenue Growth Quarters	5x
Revenue Growth Years	15x
Revenue Growth3 Y	8.43x
Revenue Growth5 Y	10.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 51.5B
Debt	INR 23.6B
Debt EBITDA	INR 0.82
Debt Equity	INR 0.17
Equity	INR 138.1B
Interest Coverage	21.01
Net Cash	INR 28B
Net Cash By Market Cap	INR 4.19
Net Cash Growth	-14.27%
Net Debt EBITDA	INR -0.99
Net Debt Equity	INR -0.2
Tangible Book Value	INR 125.1B
Tangible Book Value Per Share	INR 1,047
WACC	5.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	21.43%
Dividend Growth Years	1%
Dividend per share	INR 45
Dividend Years	11
Dividend Yield	0.81%
Ex Div Date	2026-02-20
Last Dividend	INR 43
Payout Frequency	Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	389.9%
1Y total return	11.55%
200-day SMA	5,477.3
3Y total return	64.88%
50-day SMA	5,434.8
50-day SMA vs 200-day SMA	50under200
5Y total return	101.21%
All Time High	6,439.9
All Time High Change	-13.66%
All Time High Date	2024-09-13
All Time Low	1,152.5
All Time Low Change	382.43%
All Time Low Date	2016-05-02
ATR	154.8
Beta	0.29
Beta1y	0.38
Beta2y	0.33
Ch YTD	0.97
High	5,665.5
High52	5,933.5
High52 Date	2026-01-13
High52ch	-6.29%
Low	5,550
Low52	4,716.2
Low52 Date	2025-07-10
Low52ch	17.89%
Ma50ch	2.3%
Price vs 200-day SMA	1.51%
RSI	56.69
RSI Monthly	58.25
RSI Weekly	52.96
Sharpe ratio	0.4x
Sortino ratio	0.85
Total Return	0.8%
Tr YTD	1.79
Tr1m	7.49%
Tr1w	3.72%
Tr3m	-1.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 24.9B
Operating Income Growth	12.23
Operating Income Growth Q	8.73
Operating Income Growth3 Y	25.03
Operating Income Growth5 Y	7.75
Operating margin	17.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,175,013%
Shares Insiders	46%
Shares Institutions	25.96%
Shares Out	119,565,000
Shares Qo Q	0.01%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	126,257.25x
Bv Per Share	1,116.3
Ch10y	346.5
Ch1m	7.49
Ch1w	3.72
Ch1y	10.47
Ch3m	-2.18
Ch3y	60.43
Ch5y	91.23
Ch6m	-1.91
Change	-0.55%
Change From Open	-0.5
Close	5,590.5
Days Gap	-0.04
Depreciation Amortization	3,481,750,000
Dollar Volume	309,886,600
Earnings Date	2026-05-26
EBIT	INR 24.9B
EBITDA	INR 28.4B
EPS	INR 198
F Score	1
Fiscal Year End	March
Founded	1,973
Graham Number	2231.7763
Graham Upside	-59.86
Income Tax	INR 4.2B
Is Primary Listing	1
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Lynch Fair Value	INR 1,805
Lynch Upside	-67.53
Ma150	5,559.1
Ma150ch	0.02%
Ma20	5,481.3
Ma20ch	1.44%
Next Earnings Date	2026-05-26
Open	5,588
Payment Date	2026-03-15
Position In Range	8.66
Price Date	2026-05-08
Price EBITDA	INR 23.55
Ptbv Ratio	5.34
Relative Volume	0.44x
Revenue	142,527,000,000x
Tax By Revenue	2.95x
Tax Rate	14.77%
Tr6m	-1.12%
Volume	55,735

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ALKEM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$45.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.7%

1 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2026-02-20

Performance

NSE/ALKEM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ALKEM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.0%

Share of float held by funds and institutions

Insider ownership

+46.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/ALKEM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.7

Neutral momentum band

Price vs 200-day MA

+1.5%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ALKEM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ALKEM stock rating?

nse/ALKEM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ALKEM analysis?

The full report lives at /stocks/nse/ALKEM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ALKEM?

The latest report frames nse/ALKEM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ALKEM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.